Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson's disease: A large single-center study.

Revue Neurologique(2020)

引用 9|浏览19
暂无评分
摘要
Despite the high frequency of AEs, patients with advanced PD gain clinical benefit from treatment with LCIG. This treatment requires a competent, multidisciplinary team on site.
更多
查看译文
关键词
Parkinson's disease,Levodopa-carbidopa intestinal gel,Adverse event,Gastrostomy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要